[go: up one dir, main page]

WO1999043787A3 - Matiere de reconstitution de peau chimere et vivante - Google Patents

Matiere de reconstitution de peau chimere et vivante Download PDF

Info

Publication number
WO1999043787A3
WO1999043787A3 PCT/US1999/003859 US9903859W WO9943787A3 WO 1999043787 A3 WO1999043787 A3 WO 1999043787A3 US 9903859 W US9903859 W US 9903859W WO 9943787 A3 WO9943787 A3 WO 9943787A3
Authority
WO
WIPO (PCT)
Prior art keywords
epithelial cells
dermal
skin
replacement
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/003859
Other languages
English (en)
Other versions
WO1999043787A2 (fr
Inventor
Gail K Naughton
R Emmett Pinney
Jonathan N Mansbridge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Tissue Sciences Inc
Original Assignee
Advanced Tissue Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Tissue Sciences Inc filed Critical Advanced Tissue Sciences Inc
Priority to KR1020007009299A priority Critical patent/KR20010072553A/ko
Priority to NZ506510A priority patent/NZ506510A/xx
Priority to AU33077/99A priority patent/AU760470B2/en
Priority to EP99936092A priority patent/EP1062322A2/fr
Priority to CA002324452A priority patent/CA2324452A1/fr
Priority to JP2000533527A priority patent/JP2002504412A/ja
Publication of WO1999043787A2 publication Critical patent/WO1999043787A2/fr
Publication of WO1999043787A3 publication Critical patent/WO1999043787A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des matières de reconstitution de peau destinées à favoriser la cicatrisation. Selon un mode de réalisation, la matière de reconstitution de peau est chimère et on l'obtient en prélevant des cellules épithéliales autologues sur un patient, et en les cultivant sur un substrat biocompatible contenant des cellules épithéliales allogéniques cultivées in vitro. La matière de reconstitution de peau chimère vivante peut être implantée sur une matière de reconstitution de peau permanente précédemment implantée au niveau du site de la lésion. Selon un autre mode de réalisation, la matière de reconstitution de peau est une matière composite comprenant un composant interne, intermédiaire et extérieur et, renfermant (a) un composant interne comprenant un produit de synthèse de peau biocompatible ayant un squelette biodégradable et amovible pour base; (b) un composant intermédiaire comprenant des cellules épithéliales; et (c) un composant externe comprenant des cellules épithéliales cultivées in vitro sur un produit de synthèse de peau comprenant une partie peau ayant un squelette biodégradable et amovible pour base, ladite partie peau étant combinée avec une enveloppe de transition et étant tournée vers l'intérieur dudit composant intermédiaire des cellules épithéliales. L'invention concerne également des méthodes de production et d'implantation des diverses matières de reconstitution de peau de l'invention.
PCT/US1999/003859 1998-02-24 1999-02-23 Matiere de reconstitution de peau chimere et vivante Ceased WO1999043787A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1020007009299A KR20010072553A (ko) 1998-02-24 1999-02-23 살아있는 키메릭 피부 대체물
NZ506510A NZ506510A (en) 1998-02-24 1999-02-23 A permanent skin replacement comprising allogenic epithelial cells cultured in vitro and autologous epithelial cells
AU33077/99A AU760470B2 (en) 1998-02-24 1999-02-23 A living chimeric skin replacement
EP99936092A EP1062322A2 (fr) 1998-02-24 1999-02-23 Matiere de reconstitution de peau chimere et vivante
CA002324452A CA2324452A1 (fr) 1998-02-24 1999-02-23 Matiere de reconstitution de peau chimere et vivante
JP2000533527A JP2002504412A (ja) 1998-02-24 1999-02-23 生きたキメラ皮膚置換体

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7570498P 1998-02-24 1998-02-24
US60/075,704 1998-02-24

Publications (2)

Publication Number Publication Date
WO1999043787A2 WO1999043787A2 (fr) 1999-09-02
WO1999043787A3 true WO1999043787A3 (fr) 1999-11-25

Family

ID=22127475

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/003859 Ceased WO1999043787A2 (fr) 1998-02-24 1999-02-23 Matiere de reconstitution de peau chimere et vivante

Country Status (7)

Country Link
EP (1) EP1062322A2 (fr)
JP (1) JP2002504412A (fr)
KR (1) KR20010072553A (fr)
AU (1) AU760470B2 (fr)
CA (1) CA2324452A1 (fr)
NZ (1) NZ506510A (fr)
WO (1) WO1999043787A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582725B2 (en) 2001-02-26 2009-09-01 Dermatools Biotech Gmbh Agents, which inhibit apoptosis in cells that are involved in wound healing
US9511094B2 (en) 2001-12-07 2016-12-06 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of stroke and related diseases and disorders

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964869B2 (en) 1998-07-13 2005-11-15 Wisconsin Alumni Research Foundation Method and composition for skin grafts
DE19949290A1 (de) * 1999-10-12 2001-04-26 Albrecht Bettermann Partikuläres Konstrukt zur Verwendung in der Transplantationsmedizin
CA2444699C (fr) * 2001-04-24 2012-08-07 Wisconsin Alumni Research Foundation Methode et composition destinees a des greffes cutanees
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US7741116B2 (en) 2002-03-06 2010-06-22 University Of Cincinnati Surgical device for skin therapy or testing
GB0305976D0 (en) * 2003-03-14 2003-04-23 Wild Andrew M Surgical clip
EP1970400B1 (fr) * 2005-11-24 2014-03-12 Mitsuru Akashi Gel dégradable répondant aux stimuli
EP3338549A1 (fr) * 2007-11-20 2018-06-27 Pioneer Surgical Orthobiologics, Inc. Cryoconservation de cellules utilisant des particules de matrice d'hydrogel bioactive réticulée
WO2010021993A1 (fr) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Procédés d'utilisation de cellules issues du tissu adipeux dans le traitement du système lymphatique et d'une maladie maligne
US20170296697A1 (en) * 2014-10-03 2017-10-19 Cytori Therapeutics, Inc. Use of regenerative cells in mitigating burn progression and improving skin graft incorporation and healing
CN113616540B (zh) * 2015-10-29 2023-11-03 株式会社Lg生活健康 新型闭塞制剂

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460939A (en) * 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
WO1997008295A1 (fr) * 1995-08-25 1997-03-06 Lifecell Corporation Peau reconstituee
US5610007A (en) * 1993-01-21 1997-03-11 Universite Laval Chimeric sheets of epithelial cells
US5693332A (en) * 1995-08-11 1997-12-02 The Regents Of The University Of California Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460939A (en) * 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US5610007A (en) * 1993-01-21 1997-03-11 Universite Laval Chimeric sheets of epithelial cells
US5693332A (en) * 1995-08-11 1997-12-02 The Regents Of The University Of California Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
US5693332C1 (en) * 1995-08-11 2001-01-09 Univ California Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
WO1997008295A1 (fr) * 1995-08-25 1997-03-06 Lifecell Corporation Peau reconstituee

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ROUABHIA, MAHMOUD: "Skin replacement using chimeric ( allogeneic -syngeneic) cultured epidermal sheets.", M-S (MEDECINE SCIENCES), (1996) VOL. 12, NO. 12, PP. 1370-1377., XP002116665 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582725B2 (en) 2001-02-26 2009-09-01 Dermatools Biotech Gmbh Agents, which inhibit apoptosis in cells that are involved in wound healing
US9511094B2 (en) 2001-12-07 2016-12-06 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of stroke and related diseases and disorders

Also Published As

Publication number Publication date
JP2002504412A (ja) 2002-02-12
AU760470B2 (en) 2003-05-15
NZ506510A (en) 2003-03-28
EP1062322A2 (fr) 2000-12-27
CA2324452A1 (fr) 1999-09-02
AU3307799A (en) 1999-09-15
WO1999043787A2 (fr) 1999-09-02
KR20010072553A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
WO1999043787A3 (fr) Matiere de reconstitution de peau chimere et vivante
AU3155700A (en) New biomaterials
AU5679100A (en) Biological joint construct
Kiefer et al. Round window stimulation with an implantable hearing aid (Soundbridge®) combined with autogenous reconstruction of the auricle–a new approach
AU1434799A (en) Implant made of a reabsorbable ceramic material
AU5173200A (en) Proximal femoral replacement implant and method of implanting the same
Larsson et al. Histologic evaluation of soft tissue integration of experimental abutments for bone anchored hearing implants using surgery without soft tissue reduction
EP1201204A3 (fr) Appareil et méthode pour attacher des tissus mous à une prothèse artificielle
CA2286074A1 (fr) Materiau d'implants biodegradables contenant une ceramique bioactive
WO2005034852A3 (fr) Biomateriaux et biocoacervats proteiniques, leurs procedes de fabrication et d'utilisation
WO2004087006A3 (fr) Technologies de distribution d'implants
EP1142581A3 (fr) Compositions contenant un agent de scellement tissulaire et des facteurs de croissance, qui accélérent la cicatrisation
DK0621766T3 (da) Hornhindeækvivalent-in-vitro-model
WO2005053576A3 (fr) Tuteur composite muni d'un element de tuteur interne et d'un element de tuteur externe, et procede d'utilisation du tuteur
AU2001270408A1 (en) Intervertebral disc
WO1996013286A3 (fr) Procedes et compositions de modulation de la proliferation cellulaire et de la cicatrisation
AU7441998A (en) Vascular prosthesis
Raghoebar et al. Use of cultured mucosal grafts to cover defects caused by vestibuloplasty: an in vivo study
WO2002053015A3 (fr) Composition de tissu vasculaire
AU2546401A (en) Dental prosthesis with means for the release of active substances
HK1045816A1 (zh) 角质细胞生长因子-2制剂
WO2000034442A3 (fr) Application de contrainte de cisaillement par ecoulement a des cellules de muscle lisse pour la production d'implants
Grote Reconstruction of the ossicular chain with hydroxyapatite prostheses
Ohtani et al. Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS)
Jahnke et al. Experiences with Al2O3-ceramic middle ear implants

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2000 533527

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 506510

Country of ref document: NZ

Ref document number: 1999936092

Country of ref document: EP

Ref document number: 1020007009299

Country of ref document: KR

Ref document number: 33077/99

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2324452

Country of ref document: CA

Kind code of ref document: A

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1999936092

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020007009299

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 33077/99

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1020007009299

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1999936092

Country of ref document: EP